• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEPHROURETERAL STENT; STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEPHROURETERAL STENT; STENT, URETERAL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Unspecified Infection (1930); Inflammation (1932); Swelling (2091); Urinary Tract Infection (2120); Chills (2191); Thrombosis/Thrombus (4440)
Event Date 02/07/2021
Event Type  Injury  
Event Description
Moffitt study staff were notified of the event on (b)(6) 2021 initial submission date of the report (b)(6) 2021.Subject (b)(6) is a (b)(6) female with cervical cancer who initiated treatment on (b)(6) on (b)(6) 2021.The subject is currently in week 3 receiving a total of: 1 dose of atezolizumab of 1200 mg in 20 ml with her most recent dose on (b)(6) 2021 and 3 fractions of sbrt 800 cgy per fraction on (b)(6) 2021.Sae event: g2 fever and g2 uti.This event started on (b)(6) 2021.Patient (b)(6) presented to moffitt cancer center on (b)(6) 2021 with complaints of a fever (102.4 upon admission), chills, and left leg/ankle swelling.Ua consistent with infection which was treated with ceftriaxone.Ct a/p on (b)(6) 2021 consistent with cystitis.Impression notes state interval resolution of left hydroureteronephrosis following nephroureteral stent placement, though, there is persistent delayed enhancement of the left kidney which could be infectious/inflammation.Diffuse wall thickening and enhancement of the bladder wall, possibly attributable to infection/inflammation.Patient (b)(6) had us doppler ven of lower extremity on (b)(6) 2021 which showed no sonographic evidence of dvt in left lower extremity.No leukocytosis at time of admission and patient remained afebrile overnight.No further urologic intervention necessary.On (b)(6) 2021, patient's magnesium level was 1.4 mg/dl and potassium level was low at 3.3 mmol/l­ replaced with kci and magnesium sulfate.Patient was stable at time of discharge and script was sent to patient's pharmacy for bactrim ds for 7 days.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEPHROURETERAL STENT
Type of Device
STENT, URETERAL
MDR Report Key11337667
MDR Text Key232626972
Report NumberMW5099431
Device Sequence Number1
Product Code FAD
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/16/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age41 YR
Patient Weight80
-
-